The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)

Federal funding opportunity RFA-CA-27-016 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal governments (Federally recognized)
• Special district governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Private institutions of higher education
• For profit organizations other than small businesses
• State governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Independent school districts
• Native American tribal organizations (other than Federally recognized tribal governments)
• Small businesses
• City or township governments
• County governments
• Public and State controlled institutions of higher education
• Public housing authorities/Indian housing authorities

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Eligible institution/organization for the purposes of this application is defined as an academic center/organization in the United States or Canada providing direct medical care to patients that is considered one integral organizational entity under a single financial management system and governance structure. A center/organization (e.g., an academic hospital and/or academic clinic program) for this application is distinguished from large medical centers whose primary mission is patient care. In addition to patient care, academic centers/organizations have comprehensive medical training programs, investigational pharmacies, advanced imaging facilities, and preclinical laboratories that perform basic research. The only Non-domestic (non-U.S.) Entities (Foreign Institutions) allowed in response to this NOFO are Canadian Institutions. Foreign Organizations/Foreign Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

The official record

Similar grants

• National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
  PAR-25-081 · National Institutes of Health · closes January 7, 2027
• Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
  RFA-CA-27-005 · National Institutes of Health · closes January 11, 2027
• INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
  RFA-OD-27-005 · National Institutes of Health · closes June 15, 2028
• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
  PAR-24-214 · National Institutes of Health · closes January 7, 2027
• Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
  PAR-25-079 · National Institutes of Health · closes January 7, 2027
• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
  PAR-25-148 · National Institutes of Health · closes January 7, 2028